Vexibia pachycarpa. - analogs
| Prices in pharmacies: — Instructions Vexibia pachycarpa. | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Triosteum perfoliatum ✘ (incl) Nucleospermate sodium ✘ (incl) Lac caninum ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 23% — Artemisia annua neutral
- 21% — Artemisia dracuncus neutral
- 18% — Euphorbia paralias neutral
- 16% — Cotoneaster melanocarpus neutral
- 16% — Ceratocephala testiculata neutral
- 14% — Gentiana asclepiadea neutral
- 14% — Euphorbia stepposa neutral
- 13% — Paliurus spina-christi neutral
- 12% — Coronaria flos-cuculi neutral
- 12% — Malva verticillata neutral
- 11% — Chenopodium ambrosioides neutral
- 11% — Aster alpinus neutral
- 10% — Cardamine pratensis neutral
- 10% — Maclura pomifera neutral
- 10% — Hibiscus trionum neutral
- 10% — Acroptilon repens neutral
- 10% — Pulsatilla flavescens neutral
- 10% — Polygonum convalvulus neutral
- 10% 0.5€ Betonica officinalis neutral
- 10% — Fragaria viridis neutral
- 10% — Inula vulgaris neutral
- 10% — Saxifraga palustris neutral
- 10% — Lepidium graminifolium neutral
- 10% — Oxytropis stukovii neutral
Learn more about the selection of analogues
▶
- The drug has «Vexibia pachycarpa.» no complete analogues; 25 analogs by action, the most similar - Artemisia annua .
- Medical online service has selected the best substitutes for Vexibia pachycarpa. based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Vexibia pachycarpa. to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.